CAG
SEEL

Curtis Advisory Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Curtis Advisory Group’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$2.06K – 100
2023
Q3 		$2.06K Hold
3
– – ﹤0.01% 85
2023
Q2 		$13.4K Buy
+3
New +$13.4K ﹤0.01% 89